Published in
Nature Research, Nature Communications, 1(15), 2024
DOI: 10.1038/s41467-023-44575-3
Links
Tools
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Journal article published in 2024 by
Nasser K. Altorki 
,
Zachary H. Walsh,
Johannes C. Melms ,
Jeffery L. Port,
Benjamin E. Lee,
Abu Nasar,
Cathy Spinelli,
Lindsay Caprio,
Meri Rogava,
Patricia Ho ,
Paul J. Christos,
Ashish Saxena,
Olivier Elemento ,
Bhavneet Bhinder,
Casey Ager
and other authors.
,
Zachary H. Walsh,
Johannes C. Melms ,
Jeffery L. Port,
Benjamin E. Lee,
Abu Nasar,
Cathy Spinelli,
Lindsay Caprio,
Meri Rogava,
Patricia Ho ,
Paul J. Christos,
Ashish Saxena,
Olivier Elemento ,
Bhavneet Bhinder,
Casey Ager
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 